Targeting the Mycobacterium tuberculosis transpeptidase LdtMt2 with cysteine-reactive inhibitors including ebselen
de Munnik M., Lohans CT., Lang PA., Langley GW., Malla TR., Tumber A., Schofield CJ., Brem J.
Inhibitors targeting the conserved nucleophilic cysteine of the mycobacterial l,d-transpeptidases are a potential strategy for the treatment of tuberculosis.